Gift Means Reprieve for Issues

WASHINGTON—An unexpected gift from the University of California has saved Issues in Science and Technology, the National Academy of Science's esteemed but money-losing quarterly journal of science policy. The university system's chancellors have volunteered a contribution of $150,000 a year for three years. The amount eases the magazine's $250,000 annual deficit enough for the Academy to rescind its decision to close Issues after publication next month of a summer issue. (See The Scientist

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The university system's chancellors have volunteered a contribution of $150,000 a year for three years. The amount eases the magazine's $250,000 annual deficit enough for the Academy to rescind its decision to close Issues after publication next month of a summer issue. (See The Scientist, February 23, 1987, p. 2)

The rescue was initiated by UCLA Chancellor Charles Young after he learned of the journal's impending demise at an Association of American Universities luncheon here last month. "I was shocked," he said. "The journal serves a need that no other publication fills."

The Academy continues to seek additional funds from non-academic sources, one of which is said to be the Monsanto Co. The Academy hopes to publish an autumn issue, but the departure of the magazine's three-person staff and a dearth of material make that prospect doubtful.

Young has also offered the university's help in marketing the magazine, which has ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies